Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Yee

Showing results (571-580 of 709) with videos related to

Pageof 71
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|November 28, 2022
Early microbial exposure shapes adult immunity by altering CD8+ T cell developmentCybelle Tabilas, David S Iu, Ciarán W P Daly, et al.
Leukemia & Lymphoma|July 21, 2025
BCMA-targeting BiTE molecule AMG 420 in relapsed or refractory multiple myeloma: a phase 1b open-label expansion studyCesar Rodriguez, Tulio Rodriguez, Alain Kentos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 15, 2003
Fallopian tube and primary peritoneal carcinomas associated with BRCA mutationsDouglas A Levine, Peter A Argenta, Cindy J Yee, et al.
Chest|October 17, 2025
Relationship Between Framingham 10-Year Cardiovascular Disease Risk Score and Pulse Wave Amplitude Drop Characteristics in a Sleep Clinic CohortGlenn M Stewart, Benjamin K Tong, Philip de Chazal, et al.
Genes and Immunity|August 29, 2003
Polymorphisms in interferon-induced genes and the outcome of hepatitis C virus infection: roles of MxA, OAS-1 and PKRS Knapp, L J Yee, A J Frodsham, et al.
Blood Cancer Journal|November 1, 2022
Effect of granulocyte colony-stimulating factor on toxicities after CAR T cell therapy for lymphoma and myelomaKevin Charles Miller, Patrick Connor Johnson, Jeremy S Abramson, et al.
Blood Advances|June 25, 2025
Invasive fungal disease is rare in patients with relapsed/refractory multiple myeloma treated with BCMA CAR T-cell therapyJessica S Little, Angelica Medina Pena, E Bridget Kim, et al.
AIDS (London, England)|September 19, 2025
Monitoring and risk of hepatitis B reactivation and hepatitis flare during tenofovir interruption among people with HIV and hepatitis BDouglas T Dieterich, Laurence Brunet, Ricky K Hsu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 8, 2005
Gene expression profiles associated with response to chemotherapy in epithelial ovarian cancersAmir A Jazaeri, Christopher S Awtrey, Gadisetti V R Chandramouli, et al.
Cell|June 19, 2018
Developmental Origin Governs CD8<sup>+</sup> T Cell Fate Decisions during InfectionNorah L Smith, Ravi K Patel, Arnold Reynaldi, et al.
Pageof 71

Showing results (571-580 of 709) with videos related to

Sort By:
Pageof 71
Proceedings of the National Academy of Sciences of the United States of America|November 28, 2022
Early microbial exposure shapes adult immunity by altering CD8+ T cell developmentCybelle Tabilas, David S Iu, Ciarán W P Daly, et al.
Leukemia & Lymphoma|July 21, 2025
BCMA-targeting BiTE molecule AMG 420 in relapsed or refractory multiple myeloma: a phase 1b open-label expansion studyCesar Rodriguez, Tulio Rodriguez, Alain Kentos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 15, 2003
Fallopian tube and primary peritoneal carcinomas associated with BRCA mutationsDouglas A Levine, Peter A Argenta, Cindy J Yee, et al.
Chest|October 17, 2025
Relationship Between Framingham 10-Year Cardiovascular Disease Risk Score and Pulse Wave Amplitude Drop Characteristics in a Sleep Clinic CohortGlenn M Stewart, Benjamin K Tong, Philip de Chazal, et al.
Genes and Immunity|August 29, 2003
Polymorphisms in interferon-induced genes and the outcome of hepatitis C virus infection: roles of MxA, OAS-1 and PKRS Knapp, L J Yee, A J Frodsham, et al.
Blood Cancer Journal|November 1, 2022
Effect of granulocyte colony-stimulating factor on toxicities after CAR T cell therapy for lymphoma and myelomaKevin Charles Miller, Patrick Connor Johnson, Jeremy S Abramson, et al.
Blood Advances|June 25, 2025
Invasive fungal disease is rare in patients with relapsed/refractory multiple myeloma treated with BCMA CAR T-cell therapyJessica S Little, Angelica Medina Pena, E Bridget Kim, et al.
AIDS (London, England)|September 19, 2025
Monitoring and risk of hepatitis B reactivation and hepatitis flare during tenofovir interruption among people with HIV and hepatitis BDouglas T Dieterich, Laurence Brunet, Ricky K Hsu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 8, 2005
Gene expression profiles associated with response to chemotherapy in epithelial ovarian cancersAmir A Jazaeri, Christopher S Awtrey, Gadisetti V R Chandramouli, et al.
Cell|June 19, 2018
Developmental Origin Governs CD8<sup>+</sup> T Cell Fate Decisions during InfectionNorah L Smith, Ravi K Patel, Arnold Reynaldi, et al.
Pageof 71